Atlas Trials

Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants

Clinical trial NCT03059511 · TERMINATED

Trial details

NCT number
NCT03059511
Sponsor
University Children's Hospital, Zurich
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Pharmacokinetic
Start date
2017-03-03
Primary completion
2018-01-10
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.